Posterior reversible encephalopathy syndrome – A pathology that should not be overlooked in the era of COVID-19
Open Access
- 13 March 2022
- journal article
- research article
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 56, 393.e5-393.e8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysisBMC Neurology, 2021
- Case Report: Posterior Reversible Leukoencephalopathy Syndrome (PRES) as a Biologically Predictable Neurological Association in Severe COVID-19. First Reported Case From Australia and Review of Internationally Published CasesFrontiers in Neurology, 2021
- SARS-CoV-2-associated encephalitis: arguments for a post-infectious mechanismCritical Care, 2020
- Pressing Issues in COVID-19: Probable Cause to Seize SARS-CoV-2 for Its Preferential Involvement of Posterior Circulation Manifesting as Severe Posterior Reversible Encephalopathy Syndrome and Posterior StrokesAmerican Journal of Neuroradiology, 2020
- Posterior Reversible Encephalopathy Syndrome: Clinical Features and OutcomeFrontiers in Neurology, 2020
- Positive Effect of Steroids in Posterior Reversible Encephalopathy SyndromeCase Reports in Neurology, 2019
- Hyperglycemia-induced posterior reversible encephalopathy syndrome: A rare cause of reversible blindnessJournal of Family Medicine and Primary Care, 2019
- Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndromeJournal of the Neurological Sciences, 2017
- Posterior reversible encephalopathy syndromeJournal of Neurology, 2017
- Hypoxemia, oxygen content, and the regulation of cerebral blood flowAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2016